Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Tirzepatide trials produced even better results, with the SURMOUNT-1 trial showing 15-22.5 percent body weight reduction depending on dose
Dosage adjustments are only required in patients with severe renal insufficiency
Zepbound is administered as a once-weekly subcutaneous injection, with doses starting at 2.5 mg and increasing in 2.5 mg increments after at least 4 weeks, up to a maximum of 15 mg depending on individual tolerance and treatment response
Designed for clinicians, it provides a clear framework for translating gut-related findings into personalised, actionable support strategies
US$ 26.31
US$ 22.58
US$ 25.29
US$ 24.18
US$ 25.58
US$ 24.40
US$ 28.66
US$ 22.94
US$ 22.82
